RAPS recognizes that the current situation in Ukraine impacts our members and customers on many levels. If you are directly impacted by the current situation in the region and are challenged to meet your deadlines or obligations to RAPS, please reach out to raps@raps.org so that we can defer those challenges. Your health and safety are paramount to us.

Regulatory Focus™ > News Articles > Australia, New Zealand Launch Next Phase of Regulatory Harmonization Effort

Australia, New Zealand Launch Next Phase of Regulatory Harmonization Effort

Posted 14 November 2013 | By Louise Zornoza

Australia's Therapeutic Goods Administration (TGA) and New Zealand's Medicines and Medical Devices Safety Authority (Medsafe) announced on 13 November 2013 the next stage of their joint efforts toward regulatory harmonization and the launch of a joint regulatory agency, the Australia New Zealand Therapeutic Products Agency (ANZTPA)..

This new phase of joint work will cover the next two and a half years and targets 14 activities across the following six regulatory areas: medicines (prescription and non-prescription), medicines ingredients, safety, medical devices, and biological and blood products.

The Medsafe/TGA ANZTPA Implementation Steering Committee will oversee the multiple harmonization activities to link with the ongoing Australian Blueprint reforms program and the needed timing for ANZTPA Rules and Orders development.


ANZTPA Statement

Read all Breaking News from RegLink

 

© 2022 Regulatory Affairs Professionals Society.